An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States

Pamela A. Shaw, Ruth Etzioni, Steven B. Zeliadt, Angela Mariotto, Kent Karnofski, David F. Penson, Noel S. Weiss, Eric J. Feuer

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Ecologic studies of cancer screening examine cancer mortality rates in relation to use of population screening. These studies can be confounded by treatment patterns or influenced by choice of outcome and time horizon. Interpretation can be complicated by uncertainty about when mortality differences might be expected. The authors examined these issues in an ecologic analysis of prostate-specific antigen (PSA) screening and prostate cancer mortality across nine cancer registries in the United States. Results suggested a weak trend for areas with greater PSA screening rates to have greater declines in prostate cancer mortality; however, the magnitude of this trend varied considerably with the time horizon and outcome measure. A computer model was used to determine whether divergence of mortality declines would be expected under an assumption of a clinically significant survival benefit due to screening. Given a mean lead time of 5 years, the model projected that differences in mortality between high- and low-use areas should be apparent by 1999 in the absence of other factors affecting mortality. The authors concluded that modest differences in PSA screening rates across areas, together with additional sources of variation, could have produced a negative ecologic result. Ecologic analyses of the effectiveness of PSA testing should be interpreted with caution.

Original languageEnglish (US)
Pages (from-to)1059-1069
Number of pages11
JournalAmerican journal of epidemiology
Volume160
Issue number11
DOIs
StatePublished - Dec 1 2004
Externally publishedYes

Fingerprint

Prostate-Specific Antigen
Prostatic Neoplasms
Mortality
Early Detection of Cancer
Computer Simulation
Uncertainty
Registries
Neoplasms
Outcome Assessment (Health Care)
Population

Keywords

  • Computer simulation
  • Confounding factors (epidemiology)
  • Mass screening
  • Mortality
  • Prostate-specific antigen
  • Prostatic neoplasms

ASJC Scopus subject areas

  • Epidemiology

Cite this

Shaw, P. A., Etzioni, R., Zeliadt, S. B., Mariotto, A., Karnofski, K., Penson, D. F., ... Feuer, E. J. (2004). An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States. American journal of epidemiology, 160(11), 1059-1069. https://doi.org/10.1093/aje/kwh336

An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States. / Shaw, Pamela A.; Etzioni, Ruth; Zeliadt, Steven B.; Mariotto, Angela; Karnofski, Kent; Penson, David F.; Weiss, Noel S.; Feuer, Eric J.

In: American journal of epidemiology, Vol. 160, No. 11, 01.12.2004, p. 1059-1069.

Research output: Contribution to journalArticle

Shaw, PA, Etzioni, R, Zeliadt, SB, Mariotto, A, Karnofski, K, Penson, DF, Weiss, NS & Feuer, EJ 2004, 'An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States', American journal of epidemiology, vol. 160, no. 11, pp. 1059-1069. https://doi.org/10.1093/aje/kwh336
Shaw, Pamela A. ; Etzioni, Ruth ; Zeliadt, Steven B. ; Mariotto, Angela ; Karnofski, Kent ; Penson, David F. ; Weiss, Noel S. ; Feuer, Eric J. / An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States. In: American journal of epidemiology. 2004 ; Vol. 160, No. 11. pp. 1059-1069.
@article{06de8773b8db46e5a0a718795a99573d,
title = "An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States",
abstract = "Ecologic studies of cancer screening examine cancer mortality rates in relation to use of population screening. These studies can be confounded by treatment patterns or influenced by choice of outcome and time horizon. Interpretation can be complicated by uncertainty about when mortality differences might be expected. The authors examined these issues in an ecologic analysis of prostate-specific antigen (PSA) screening and prostate cancer mortality across nine cancer registries in the United States. Results suggested a weak trend for areas with greater PSA screening rates to have greater declines in prostate cancer mortality; however, the magnitude of this trend varied considerably with the time horizon and outcome measure. A computer model was used to determine whether divergence of mortality declines would be expected under an assumption of a clinically significant survival benefit due to screening. Given a mean lead time of 5 years, the model projected that differences in mortality between high- and low-use areas should be apparent by 1999 in the absence of other factors affecting mortality. The authors concluded that modest differences in PSA screening rates across areas, together with additional sources of variation, could have produced a negative ecologic result. Ecologic analyses of the effectiveness of PSA testing should be interpreted with caution.",
keywords = "Computer simulation, Confounding factors (epidemiology), Mass screening, Mortality, Prostate-specific antigen, Prostatic neoplasms",
author = "Shaw, {Pamela A.} and Ruth Etzioni and Zeliadt, {Steven B.} and Angela Mariotto and Kent Karnofski and Penson, {David F.} and Weiss, {Noel S.} and Feuer, {Eric J.}",
year = "2004",
month = "12",
day = "1",
doi = "10.1093/aje/kwh336",
language = "English (US)",
volume = "160",
pages = "1059--1069",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States

AU - Shaw, Pamela A.

AU - Etzioni, Ruth

AU - Zeliadt, Steven B.

AU - Mariotto, Angela

AU - Karnofski, Kent

AU - Penson, David F.

AU - Weiss, Noel S.

AU - Feuer, Eric J.

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Ecologic studies of cancer screening examine cancer mortality rates in relation to use of population screening. These studies can be confounded by treatment patterns or influenced by choice of outcome and time horizon. Interpretation can be complicated by uncertainty about when mortality differences might be expected. The authors examined these issues in an ecologic analysis of prostate-specific antigen (PSA) screening and prostate cancer mortality across nine cancer registries in the United States. Results suggested a weak trend for areas with greater PSA screening rates to have greater declines in prostate cancer mortality; however, the magnitude of this trend varied considerably with the time horizon and outcome measure. A computer model was used to determine whether divergence of mortality declines would be expected under an assumption of a clinically significant survival benefit due to screening. Given a mean lead time of 5 years, the model projected that differences in mortality between high- and low-use areas should be apparent by 1999 in the absence of other factors affecting mortality. The authors concluded that modest differences in PSA screening rates across areas, together with additional sources of variation, could have produced a negative ecologic result. Ecologic analyses of the effectiveness of PSA testing should be interpreted with caution.

AB - Ecologic studies of cancer screening examine cancer mortality rates in relation to use of population screening. These studies can be confounded by treatment patterns or influenced by choice of outcome and time horizon. Interpretation can be complicated by uncertainty about when mortality differences might be expected. The authors examined these issues in an ecologic analysis of prostate-specific antigen (PSA) screening and prostate cancer mortality across nine cancer registries in the United States. Results suggested a weak trend for areas with greater PSA screening rates to have greater declines in prostate cancer mortality; however, the magnitude of this trend varied considerably with the time horizon and outcome measure. A computer model was used to determine whether divergence of mortality declines would be expected under an assumption of a clinically significant survival benefit due to screening. Given a mean lead time of 5 years, the model projected that differences in mortality between high- and low-use areas should be apparent by 1999 in the absence of other factors affecting mortality. The authors concluded that modest differences in PSA screening rates across areas, together with additional sources of variation, could have produced a negative ecologic result. Ecologic analyses of the effectiveness of PSA testing should be interpreted with caution.

KW - Computer simulation

KW - Confounding factors (epidemiology)

KW - Mass screening

KW - Mortality

KW - Prostate-specific antigen

KW - Prostatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=9344235041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9344235041&partnerID=8YFLogxK

U2 - 10.1093/aje/kwh336

DO - 10.1093/aje/kwh336

M3 - Article

C2 - 15561985

AN - SCOPUS:9344235041

VL - 160

SP - 1059

EP - 1069

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 11

ER -